Renal Physicians Association Kidney Quality Improvement Registry, Powered by Premier, Inc non-mips Measure Specifications

Similar documents
The Renal Physicians Association Quality Improvement Registry

Quality ID #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care

Measure #330: Adult Kidney Disease: Catheter Use for Greater Than or Equal to 90 Days National Quality Strategy Domain: Patient Safety

Measure #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care

NATIONAL QUALITY FORUM Renal EM Submitted Measures

Sid Bhende MD Sentara Vascular Specialists April 28 th Dialysis Access Review: Understanding the Access Options our Patients Face

April 18, Dear Mr. Blum and Dr. Conway:

Lesson #7: Quality Assessment and Performance Improvement

Delineation Of Privileges Vascular Surgery Privileges

Quality ID #119 (NQF 0062): Diabetes: Medical Attention for Nephropathy National Quality Strategy Domain: Effective Clinical Care

Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality

2018 HEMODIALYSIS CATHETERS CODING AND REIMBURSEMENT GUIDE

Nephrology. 2. To facilitate a trainee to acquire the knowledge, clinical skills, procedural competence and professional attributes in Nephrology.

Vascular Access Care Plans: How Can a Care Plan Really Improve Care and Make Everyone s Job Easier?

Thrombectomy, open, arteriovenous fistula without revision, autogenous or nonautogenous dialysis graft (separate procedure)

DENOMINATOR: Patients aged 18 and older with infrarenal non-ruptured endovascular AAA repairs

End-Stage Renal Disease. Anna Vinnikova, M.D. Associate Professor of Medicine Division of Nephrology

Staff-Assisted Home Hemodialysis

Measure #167 (NQF 0114): Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure National Quality Strategy Domain: Effective Clinical Care

Reporting Periods in 2010

Delineation of Privileges Department of Internal Medicine / Nephrology

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Intermediate Outcome

Decreased Incidence of Clotted AV Access in Hemodialysis Patients after the Implementation of Follow up Program

Hemodialysis Vascular Access Procedures

Measure #164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clinical Care

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

Quality ID #236 (NQF 0018): Controlling High Blood Pressure National Quality Strategy Domain: Effective Clinical Care

Introduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge.

Measure #403: Adult Kidney Disease: Referral to Hospice National Quality Strategy Domain: Patient and Caregiver-Centered Experience and Outcomes

Medical Director/Surgeon as Partners WebEx February 11, 2010


Dialysis circuit procedures: arteriovenous (AV) fistula repair

morbidity & mortality

ASDIN 8th Annual Scientific Meeting

Utopia Health Career Center, LLC. Do not distribute without permission.

Incident Hemodialysis

State Profile for FY 2018 for Dialysis Patients and Facilities - STATE SAMPLE

Current treatment status and medical costs for hemodialysis vascular access based on analysis of the Korean Health Insurance Database

Quality ID #122: Adult Kidney Disease: Blood Pressure Management National Quality Strategy Domain: Effective Clinical Care

KIDNEY FAILURE TREATMENT OPTIONS Choosing What s Best For You

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge.

Dialysis Event Protocol

Chapter Five Clinical indicators & preventive health

Technical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access

2013 Bundled Payments / QIP Presented by John Greenacre

Dr. Murty Mantha MD FRACP Cairns Base Hospital Cairns. DNT 2011 Hunter Valley

JVA ISSN Hemodialysis vascular access management in the Netherlands. Introduction ORIGINAL ARTICLE

Vascular access. The KidneyCare Audit

2014 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

Surgical Privileges Form: Vascular Surgery

Specific Basic Standards for Osteopathic Fellowship Training in Nephrology

Difference in practical dialysis therapy between East Asia and US/EU

2010 Physician Quality Reporting Initiative Measures Groups Specifications Manual

IN.PACT AV Access IDE Study Full Baseline Data. Robert Lookstein, MD MHCDL New York, NY On Behalf of the IN.PACT AV ACCESS Investigators

End Stage Kidney Disease Among Indigenous Peoples of Australia and New Zealand

mean hemoglobin 11 g/dl (110 g/l) compared to patients with lower mean hemoglobin values (Table 20).

2008 Dialysis Facility Report

St George Hospital Renal Department Internal Policy

ASDIN 7th Annual Scientific Meeting

RPA Quality Improvement Registry in collaboration with CECity

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Comprehensive ESRD Care (CEC) Model Proposed Quality Measures for Public Comment. Table of Contents

Regardless of whether you are a vascular surgeon,

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

Provider Type. Service Place

The HeRO Graft. Shawn M. Gage, PA Division of Vascular Surgery Duke University Medical Center

Chapter 8: Cardiovascular Disease in Patients with ESRD

*NOTE: When reporting C P T code and 99239, it is recommended the measure be reported each time the code is submitted for hospital discharge.

CATHETER REDUCTION. Angelo N. Makris, M.D. Medical Director Chicago Access Care

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York

CHAPTER 5. Haemodialysis. Kevan Polkinghorne Hannah Dent Aarti Gulyani Kylie Hurst Stephen McDonald

Measure Information Form

PALLIATIVE CARE FOR PATIENTS AND FAMILIES LIVING WITH CKD AND ESRD

Living Kidney Donation. Dr. Joseph Keith Melancon

2) Patients who are 18 years and older with a diagnosis of CAD or history of cardiac surgery who have a prior myocardial infarction

Vascular Access Options for Apheresis Medicine

Arkansas Health Care Payment Improvement Initiative Percutaneous Coronary Intervention Algorithm Summary

United States Renal Data System (USRDS) International Data Collection Form

THERE ARE TWO SUBMISSION CRITERIA FOR THIS MEASURE: 1) Patients who are 18 years and older with a diagnosis of CAD with LVEF < 40%

Renal Physicians Association s Kidney Quality Improvement Registry

Kidney Decisions Aid

Quality ID #457 (NQF 0216): Proportion Admitted to Hospice for less than 3 days- National Quality Strategy Domain: Effective Clinical Care

Outcomes Of Combined Rheolytic And Rotational Mechanical Thrombectomy For Total Access Circuit Thrombosis In Hemodialysis Patients

QBPC Claims Based Provider Quick Reference Guide

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Outcome High Priority

Postoperative AV Fistula Evaluation. Postoperative examination protocol. Postoperative AVF Protocol. Hemodialysis Access Surveillance

Cardiovascular disease profile

Transcatheter therapy, venous infusion for thrombolysis, any method, including radiological supervision and interpretation, initial treatment day

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2019 ABBOTT REIMBURSEMENT GUIDE CMS Physician Fee Schedule

Acceptance onto dialysis guidelines: St George Hospital

Gerald Beathard Annual State of the Art Lecture Innovations in Vascular Access - Have We Moved Forward?

Division of Medicine. Department of Nephrology. Staff. Mauro Braun, M.D. Beth Leventhal Fromkin, M.D.

What s on the Horizon in Dialysis Access? Libby Watch, MD, FACS Miami Cardiac & Vascular Institute

Basics of Interventional Radiology Coding 2018

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

RadRx Your Prescription for Accurate Coding & Reimbursement Copyright All Rights Reserved.

Transcription:

Renal Physicians Association Kidney Quality Improvement Registry, Powered by Premier, Inc. 2018 non-mips Measure Specifications Last updated January 2, 2018

RPAQIR1: Angiotensin Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy- National Quality Strategy Domain: Effective Clinical Care Process Percentage of patients aged 18 years and older with a diagnosis of CKD (Stages 1-5, not receiving RRT) and proteinuria who were prescribed ACE inhibitor or ARB therapy within a 12-month period Once per measurement period DENOMINAT: All patients aged 18 years and older with a diagnosis of chronic kidney disease (CKD) (Stages 1-5, not receiving renal replacement therapy [RRT]) and proteinuria Diagnosis of CKD (Stages 1-5) (ICD10): N18.1, N18.2, N18.3, N18.4, N18.5, E11.22 AND Diagnosis of Proteinuria (ICD10): R80.1, R80.8, R80.9 AND Patient encounter during the performance period (CPT): 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99304, 99305, 99306, 99307, 99308, 99309, 99310, 99324, 99325, 99326, 99327,99328, 99334, 99335, 99336, 99337, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350 AND NOT DENOMINAT EXCLUSIONS: Receiving Renal Replacement Therapy (RRT): N18.6, Z49. 31, Z49.32, Z99.2, 90951, 90952, 90953, 90954, 90955, 90956, 90957, 90958, 90959, 90960, 90961, 90962, 90963, 90964, 90965, 90966, 90967, 90968, 90969, 90970, I70.1 NUMERAT: Patients who were prescribed angiotensin converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) therapy during the measurement period Denominator Exception: Denominator Exception: ACE inhibitor or ARB therapy prescribed during the measurement period (RPAQIR_1.NUMER.1.YES) ACE inhibitor or ARB therapy not prescribed during the measurement period, medical reason(s) documented (e.g., pregnancy, history of angioedema to ACEI, other allergy to ACEI and ARB, hyperkalemia or history of hyperkalemia while on ACEI or ARB therapy, acute kidney injury due to ACEI or ARB therapy, other medical reasons (RPAQIR_1.NUMER.2.YES) ACE inhibitor or ARB therapy not prescribed during the measurement period, patient reason(s) documented (e.g., patient declined, other patient reasons) (RPAQIR_1.NUMER.3.YES)

ACE inhibitor or ARB therapy not prescribed during the measurement period, other reason(s) or reason not otherwise specified (RPAQIR_1.NUMER.4.NO)

RPAQIR2: Adequacy of Volume Management - National Quality Strategy Domain: Effective Clinical Care Process Percentage of calendar months within a 12-month period during which patients aged 18 years and older with a diagnosis of ESRD undergoing maintenance hemodialysis in an outpatient dialysis facility have an assessment of the adequacy of volume management from a nephrologist Once per calendar month DENOMINAT: All calendar months during which patients aged 18 years and older with a diagnosis of end-stage renal disease (ESRD) are undergoing maintenance hemodialysis in an outpatient dialysis facility Diagnosis of ESRD (ICD10): N18.6 AND Patient encounter for maintenance hemodialysis during the performance period (CPT): 90957, 90958, 90959, 90960, 90961, 90962, [TK1]90969, 90970 NUMERAT: Patients with an assessment of the adequacy of volume management during the calendar month of the encounter Definition Adequacy of Volume Management - Adequacy of volume management for a patient on dialysis is determined by assessing whether or not the patient achieved the prescribed patient-specific target end dialysis weight after receiving dialysis. This is determined by comparing the prescribed patient-specific target end dialysis weight and the actual measured post dialysis weight (weight at the end of the dialysis treatment). The patient had an assessment of the adequacy of volume management during the calendar month of the encounter (RPAQIR_2.NUMER.1.YES) The patient did not have an assessment of the adequacy of volume management during the calendar month of the encounter (RPAQIR_2.NUMER.2.NO)

RPAQIR4: Arteriovenous Fistula Rate- National Quality Strategy Domain: Effective Clinical Care Process Percentage of calendar months within a 12-month period during which patients aged 18 years and older with a diagnosis of ESRD and receiving maintenance hemodialysis are using an autogenous arteriovenous (AV) fistula with two needles in an outpatient dialysis facility. Once per calendar month DENOMINAT: All calendar months within a 12-month period during which patients aged 18 years and older with a diagnosis of end-stage renal disease (ESRD) are undergoing maintenance hemodialysis in an outpatient dialysis facility. Diagnosis of ESRD (ICD10): N18.6 AND Patient Encounter for maintenance hemodialysis during the performance period (CPT): 90957, 90958, 90959, 90960, 90961, 90962, [TK2]90969, 90970 NUMERAT: Calendar months during which patients are using an autogenous arteriovenous (AV) fistula with two needles Denominator Exception Denominator Exception (AV) fistula with two needles used for hemodialysis in the calendar month of this visit (RPAQIR_4.NUMER.1.YES) The patient did not have an (AV) fistula with two needles used for hemodialysis in the calendar month of this visit, medical reason(s) documented (e.g., patient has a functioning AV graft, patient is undergoing palliative dialysis with a catheter, patient already referred to or approved by a qualified transplant program and scheduled to receive a living donor kidney transplant, other medical reasons).(rpaqir_4.numer.2.yes) The patient did not have an (AV) fistula with two needles used for hemodialysis in the calendar month of this visit, patient reason(s) documented (e.g., patient declined fistula placement, other patient reasons). (RPAQIR_4.NUMER.3.YES) The patient did not have an (AV) fistula with two needles used for hemodialysis in the calendar month of this visit, no reason or other reason(s) documented (RPAQIR_4.NUMER.4.NO)

RPAQIR5: Transplant Referral - National Quality Strategy Domain: Communication and Care Coordination Process Percentage of patients aged 18 years and older with a diagnosis of ESRD on hemodialysis or peritoneal dialysis for 90 days or longer who are referred to a transplant center for kidney transplant evaluation within a 12-month period Once per measurement period. DENOMINAT: All patients aged 18 years and older with a diagnosis of end-stage renal disease (ESRD) on hemodialysis or peritoneal dialysis for 90 days or longer Diagnosis of ESRD (ICD10): N18.6 AND Patient Encounter for hemodialysis or peritoneal dialysis for 90 days or longer during the performance period (CPT): 90957, 90958, 90959, 90960, 90961, 90962, 90965, 90966, 90969, 90970 NUMERAT: Patients who are referred to a transplant center for kidney transplant evaluation within a 12-month period Denominator Exception Denominator Exception Denominator Exception The patient was referred to a transplant center for kidney transplant evaluation during the measurement period (RPAQIR_5.NUMER.1.YES) The patient was not referred to a transplant center for kidney transplant evaluation during the measurement period, medical reason(s) documented (e.g., patient not receiving dialysis for 90 days or longer, patient undergoing palliative dialysis, patient already referred or approved by a qualified transplant program and scheduled to receive a living donor kidney transplant, other medical reasons) (RPAQIR_5.NUMER.2.YES) The patient was not referred to a transplant center for kidney transplant evaluation during the measurement period, patient reason(s) documented (e.g., patient declined, other patient reasons) (RPAQIR_5.NUMER.3.YES) The patient was not referred to a transplant center for kidney transplant evaluation during the measurement period, system reason(s) documented (e.g., lack of insurance coverage, nearest facility too far away, other system reasons) (RPAQIR_5.NUMER.4.YES)

The patient was not referred to a transplant center for kidney transplant evaluation during the measurement period, no reason or other reason(s) documented (RPAQIR_5.NUMER.5.NO)

RPAQIR9: Advance Care Planning (Pediatric Kidney Disease) - National Quality Strategy Domain: Person and Caregiver-Centered Experience and Outcomes Process Percentage of patients aged 17 years and younger with a diagnosis of ESRD on hemodialysis or peritoneal dialysis for whom there is documentation of a discussion regarding advance care planning Once per measurement period DENOMINAT: Patients aged 17 years and younger with a diagnosis of ESRD on hemodialysis or peritoneal dialysis Diagnosis of ESRD (ICD10): N18.6 AND Patient Encounter for hemodialysis or peritoneal during the performance period (CPT): 90951, 90952, 90953, 90954, 90955, 90956, 90957, 90958, 90959, 90963, 90964, 90965,, 90967, 90968, 90969, Z99.2 NUMERAT: Patients for whom there is documentation of a discussion regarding advance care planning. Definition Discussion - Discussion should result in a plan to establish treatment goals based on patient's medical condition and prognosis. Discussion must endorse a family centered approach, and treatment goals must be determined. The benefits and burdens of dialysis should be discussed, and the quality of the life of the individual be taken into account. Kidney transplant should be discussed if appropriate. Although the discussion can take place with other providers, the physician overseeing the dialysis should confirm that the conversation has been undertaken either 1. Directly by the nephrologist or dialysis center staff, or 2. By another physician overseeing the patient s care. Documentation of a discussion regarding advance care planning during the measurement period (99497) No documentation of a discussion regarding advance care planning during the measurement period (RPAQIR_9.NUMER.2.NO)

RPAQIR11: Hospitalization Rate Following Procedures Performed under Procedure Sedation Analgesia - National Quality Strategy Domain: Effective Clinical Care Outcome Percentage of inpatient hospitalizations immediately following procedures performed on patients aged 18 years and older under procedure sedation analgesia Every denominator eligible visit during the measurement period DENOMINAT: Procedures performed under procedure sedation analgesia for patients aged 18 years and older. Procedures Include: Ultrasound-guided renal biopsy Insertion/maintenance of peritoneal dialysis (PD) catheters for CKD/ESRD Insertion/maintenance of tunneled hemodialysis catheters for ESRD Percutaneous endovascular procedures performed to manage dysfunction of arteriovenous fistulas/grafts for CKD/ESRD Percutaneous placement/maintenance/removal of port catheter Percutaneous placement of central venous catheter (CVC) (non dialysis) Insertion/maintenance of tunneled CVC (non dialysis) Eligible procedure during the performance period (CPT): 36556, 36558, 36561, 49418, 49421, 50200, 36565, 36581, 36582, 36901, 36902, 36903, 36904, 36905, 36906, 36907, 36908, 36909, 49422 AND Sedation analgesia during the performance period (CPT): 99152, 99153 AND NOT DENOMINAT EXCLUSION: Procedures performed while patient is inpatient status: RPAQIR_11.DEN.1.YES NUMERAT: Patients who are hospitalized in an inpatient setting (including 23-hour observations) that occur immediately following the procedure Numerator Instructions: INVERSE MEASURE- A lower calculated performance rate for this measure indicates better clinical care or control. The Performance Not Met numerator option for this measure is the representation of the better clinical quality or control. Reporting that numerator option will produce a performance rate that trends closer to 0%, as quality increases. For inverse measures, a rate of 100% means all of the denominator eligible patients did not receive the appropriate care or were not in proper control. Denominator Exception: Patient was hospitalized immediately following the procedure, no reason or other reason(s) documented (RPAQIR_11.NUMER.1.YES) Patient was hospitalized immediately following the procedure, medical reason(s) documented (e.g., Patient admitted for 23- hour observation for renal biopsy or patient admitted for other reasons unrelated to the procedure) (RPAQIR_11.NUMER.2.YES)

Denominator Exception: Patient was hospitalized immediately following the procedure, patient reason(s) documented (e.g., Elective admission) (RPAQIR_11.NUMER.3.YES) Patient was not hospitalized immediately following the procedure (RPAQIR_11.NUMER.4.NO)

RPAQIR12: Arterial Complication Rate Following Arteriovenous Access Intervention - National Quality Strategy Domain: Patient Safety Outcome Percentage of arterial complications in patients aged 18 years and older following angiography, angioplasty or thrombectomy procedures Every denominator eligible visit during the measurement period DENOMINAT: Patients aged 18 years or older with angiography, angioplasty, thrombectomy procedures, including: Mechanical/chemical thrombectomies of clotted hemodialysis catheters Angiograms Angioplasty Stent placement Mechanical thrombectomies of clotted AVFs and AVGs Accessory vein ligation Eligible procedure during the performance period (CPT): 36901, 36902, 36903, 36904, 36905, 36906, 37220, 37221, 37222, 37223 37224, 37225, 37226, 37227, 37228, 37229, 37230, 37231, 37232, 37233, 37234, 37235, 37236, 37238, 37607, 75710 NUMERAT: Number of patients with arterial complications (Arterial embolization, dissection, and arterial compromise thrombosis) that occur 24 hours following the procedure Numerator Instructions: INVERSE MEASURE- A lower calculated performance rate for this measure indicates better clinical care or control. The Performance Not Met numerator option for this measure is the representation of the better clinical quality or control. Reporting that numerator option will produce a performance rate that trends closer to 0%, as quality increases. For inverse measures, a rate of 100% means all of the denominator eligible patients did not receive the appropriate care or were not in proper control. Patient had arterial complications within 24 hours following the procedure (RPAQIR_12.NUMER.1.YES) Patient did not have arterial complications within 24 hours following the procedure (RPAQIR_12.NUMER.2.NO)

RPAQIR13: Rate of Timely Documentation Transmission to Dialysis Unit/Referring Physician- National Quality Strategy Domain: Communication and Care Coordination Process Percentage of patients aged 18 years and older for whom documentation is sent to the dialysis unit or referring physician within two days of the procedure completion or consultation Every denominator eligible visit during the measurement period DENOMINAT: Patients who received a procedure or consultation. Procedures include: Ultrasonography of kidneys Ultrasonography of AVF/AVG Ultrasonography of peritoneal dialysis catheter Arteriovenous fistula/graph physical exam Physical exam prior to scheduled procedure Ultrasound-guided renal biopsy Insertion/maintenance of peritoneal dialysis (PD) catheters for CKD/ESRD Insertion/maintenance of tunneled hemodialysis catheters for ESRD Percutaneous endovascular procedures performed to manage dysfunction of arteriovenous fistulas/grafts for CKD/ESRD Percutaneous placement/maintenance/removal of port catheter Percutaneous placement of central venous catheter (CVC) (non dialysis) Insertion/maintenance of tunneled CVC (non dialysis) Eligible procedure during the performance period (CPT): 36556, 36558, 36561, 36566, 36571, 36578, 36582, 36590, 36901, 36902, 36903, 36904, 36905, 36906, 36907, 36908, 36909, 49418, 49421, 76770, 76937, 76942, 93990 NUMERAT: Patients for whom documentation was sent to the dialysis unit or referring physician within 2 days of the procedure completion or consultation Documentation was sent to the dialysis unit or referring physician within 2 days of the procedure completion or consultation (RPAQIR_13.NUMER.1.YES) Documentation was not sent to the dialysis unit or referring physician within 2 days of the procedure completion or consultation (RPAQIR_13.NUMER.2.NO)

RPAQIR14: Arteriovenious Graft Thrombectomy Success Rate- National Quality Strategy Domain: Effective Clinical Care Outcome Percentage of clinically successful arteriovenous graft (AVG) thrombectomies for patients aged 18 years and older Every denominator eligible visit during the measurement period DENOMINAT: Patients aged 18 years and older with attempted AVG thrombectomies Eligible procedure during the performance period (CPT): 36904, 36905, 36906 NUMERAT: AVF thrombectomies for which the procedure was clinically successful. Clinical success is defined as able to dialyze successfully with 2 needles for one treatment once with that access post procedure. Denominator Exception: Successful arteriovenous graft (AVG) thrombectomy (RPAQIR_14.NUMER.1.YES) Procedure was for AVF thrombectomy (RPAQIR_14.NUMER.2.YES) Unsuccessful arteriovenous graft (AVG) thrombectomy (RPAQIR_14.NUMER.3.NO)

RPAQIR15: Arteriovenous Fistulae Thrombectomy Success Rate - National Quality Strategy Domain: Effective Clinical Care Outcome Percentage of clinically successful arteriovenous fistulae (AVF) thrombectomies for patients aged 18 years and older Every denominator eligible visit during the measurement period DENOMINAT: Patients aged 18 years and older with attempted AVF thrombectomies Eligible procedure during the performance period (CPT): 36904, 36905, 36906 NUMERAT: AVF thrombectomies for which the procedure was clinically successful. Clinical success is defined as able to dialyze successfully once with two needles using that access post procedure. Denominator Exception: Successful arteriovenous graft (AVF) thrombectomy (RPAQIR_15.NUMER.1.YES) Procedure was for AVG thrombectomy (RPAQIR_15.NUMER.2.YES) Unsuccessful arteriovenous graft (AVF) thrombectomy (RPAQIR_15.NUMER.3.NO)

RPAQIR16: Peritoneal Dialysis Catheter Success Rate - National Quality Strategy Domain: Effective Clinical Care Outcome Percentage of clinically successful peritoneal dialysis (PD) catheter placements in patients aged 18 years and older Every denominator eligible visit during the measurement period DENOMINAT: Patients aged 18 years and older receiving renal replacement therapy with PD catheters placed. Eligible procedure for PD catheter placement during the performance period (CPT): 49418, 49421 49324 AND NOT DENOMINAT EXCLUSIONS Documentation of kidney transplant: Z94.0 Patient death before first use of catheter: RPAQIR_16.DEN.1.YES NUMERAT: PD catheters placement for which the procedure was clinically successful Definition Successful Placement - Use of PD catheter for renal replacement therapy without any further invasive intervention. Further invasive intervention includes: Peritoneal dialysis (PD) catheter Placement PD catheter removal PD catheter revision Catheter exchange Laparoscopic revision/catheter relocation Omentectomy Adhesiolysis Fluoroscopic/peritoneogram/catheter relocation External cuff removal/shave Mechanical fibrin plug removal PD catheter placement clinically successful (RPAQIR_16.NUMER.1.YES) Unsuccessful catheter placement (RPAQIR_16.NUMER.2.NO); 44180, 49325, 49326, 49422, 49424

RPAQIR17: Peritoneal Dialysis Catheter Exit Site Infection Rate - National Quality Strategy Domain: Patient Safety Outcome Percentage of patients aged 18 years and older with an exit site infection within 2 weeks of a peritoneal dialysis (PD) catheter invasive intervention Every denominator eligible visit during the measurement period DENOMINAT: Patients aged 18 years and older who had an invasive intervention performed on a PD catheter Eligible procedure for invasive intervention on a PD catheter performed during the performance period (CPT): 44180, 49255, 49325, 49421, 49422, 49435, 49326, 49418, 49436 NUMERAT: Patients with an exit site infection within two weeks after a PD catheter invasive intervention Numerator Instructions: INVERSE MEASURE- A lower calculated performance rate for this measure indicates better clinical care or control. The Performance Not Met numerator option for this measure is the representation of the better clinical quality or control. Reporting that numerator option will produce a performance rate that trends closer to 0%, as quality increases. For inverse measures, a rate of 100% means all of the denominator eligible patients did not receive the appropriate care or were not in proper control. The patient had an exit site infection within two weeks of the PD catheter invasive intervention (RPAQIR_17.NUMER.1.YES) The patient did not have an exit site infection within two weeks of the PD catheter invasive intervention (RPAQIR_17.NUMER.2.NO)

RPAQIR18: Advance Directives Completed - National Quality Strategy Domain: Person and Caregiver- Centered Experience and Outcomes Process Percentage of patients aged 18 years and older with a diagnosis of Stage 3, 4 & 5 chronic kidney disease (CKD) or end-stage renal disease (ESRD) who have advance directives or end of life medical orders completed based on their preferences Once per measurement period DENOMINAT: All patients aged 18 years and older with a diagnosis of Stage 3, 4, or 5 CKD (including patients with end-stage renal disease and transplant recipients) Diagnosis of CKD Stage 3, 4, or 5 or ESRD (ICD10): N18.3, N18.4, N18.5, N18.6 AND Patient Encounter (in office or dialysis facility) (CPT): 90957, 90958, 90959, 90960, 90961, 90962, 90965, 90966, 90969, 90970, 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99304, 99305, 99306, 99307, 99308, 99309, 99310, 99324, 99325, 99326, 99327, 99328, 99334, 99335, 99336, 99337, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350 NUMERAT: Patients who have advance directives or end-of-life medical orders completed Advanced directives or end-of-life medical orders completed (RPAQIR_18.NUMER.1.YES) Denominator Exception: Advanced directives or end-of-life medical orders not completed, patient reasons documented (e.g., patient declined, other patient reasons) (RPAQIR_18.NUMER.2.YES) Advanced directives or end-of-life medical orders not completed, no reason or other reason(s) documented (RPAQIR_18.NUMER.3.NO)